Clinical Trial

Cantargia Reports Timelines for Nadunolimab Clinical Trials in Leukemia and Triple Negative Breast Cancer

LUND, SE / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported currently…

5 months ago

Fujitsu tackles ‘drug loss’ in Japan through ecosystem to accelerate digitalization of clinical trials

Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI TOKYO, Aug. 26, 2024…

5 months ago

Sanford Health Partners with Infor to Unify Critical Business Applications in the Cloud

Infor CloudSuite Healthcare to Better Link People to Processes NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Infor, the industry cloud…

5 months ago

Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter

Embarking on a journey to ultimately becoming AI's nose capable of digitizing smellAI Nose journey begins in healthcare and is…

5 months ago

MIRA Pharmaceuticals Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study

Study Highlights Superior Efficacy of Ketamir-2 Over Oral Ketamine, Achieving Full Normalization of Pain ThresholdsMIAMI, FL / ACCESSWIRE / August…

5 months ago

MPOX is Emerging as a Global Threat – NanoViricides Investigating MEURI Protocol for Using NV-387 to Treat MPOX

SHELTON, CT / ACCESSWIRE / August 26, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader…

5 months ago

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company

PASADENA, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”),…

5 months ago

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today…

5 months ago

Halberd Corp. Issues Letter to Shareholders

JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to…

5 months ago